Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Parasite Immunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1400308

Humoral and cellular Immunity in response to in silico designed multiepitope recombinant protein of Theileria annulata

Provisionally accepted
Asadullah Abid Asadullah Abid 1Ambreen Khalid Ambreen Khalid 1Muhammad Suleman Muhammad Suleman 2*Haroon Akbar Haroon Akbar 1Mian Hafeez Mian Hafeez 1Jawaria A. Khan Jawaria A. Khan 3Muhammad Imran Rashid Muhammad Imran Rashid 1*
  • 1 Department of Parasitology, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan
  • 2 Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan
  • 3 Department of Clinical Medicine and Surgery, University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan

The final, formatted version of the article will be published soon.

    Tropical theileriosis is a lymphoproliferative disease caused by Theileria annulata and is transmitted by Ixodid ticks of genus Hyalomma. It causes significant loss in livestock, especially in exotic cattle. The existing methods of its control by chemotherapeutic agents and available vaccine, based on attenuated schizont staged parasite, have several limitations. A promising solution to control this disease is the use of molecular vaccines based on potential immunogenic proteins of T. annulata. For this purpose, we have selected 5 antigenic sequences of T. annulata i.e. SPAG-1, Tams, TaSP, spm2 and Ta9. These were subjected to epitope prediction for Cytotoxic T-lymphocytes, B-cells and Helper T-lymphocytes. The epitopes having higher score for CTL and B-cell epitopes; and least percentile score for HTL epitopes were selected. A single protein was constructed using specific linkers and evaluated for higher antigenicity and least allergenicity. The construct was acidic, hydrophobic and thermostable in nature. Secondary and tertiary structures of this construct were drawn from PSIPred and RaptorX servers respectively. The Ramachandran plot shows a high percentage of residues of this construct in favorable, allowed and general region. Molecular docking studies suggest that the complex is stable and our construct could be potentially a good candidate for immunization trials. Further we have successfully cloned it to pET-28a plasmid and transformed it in BL21 strain. A restriction analysis was performed to confirm the transformation of our plasmid. After expression and purification, recombinant protein of 49kDa was confirmed on western blot. ELISA results detected raised specific antibody levels in immunized animals' sera when compared to control group and flow cytometric analysis shows the stronger cell mediated immune response. We believe our multi-epitope recombinant protein has the potential for the large-scale application for disease prevention globally in bovine population. This study will act as a model for similar parasitic challenges.

    Keywords: immunoinformatics, Multi-epitope, Theileria annulata, molecular docking, epitope prediction, Flow Cytometry

    Received: 13 Mar 2024; Accepted: 24 Jul 2024.

    Copyright: © 2024 Abid, Khalid, Suleman, Akbar, Hafeez, Khan and Rashid. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Muhammad Suleman, Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan
    Muhammad Imran Rashid, Department of Parasitology, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.